Almirall, S.A.

Almirall, S.A.

LBTSF - Insider Information

Get informed when a big investor buys or sells

+ Follow
Market Cap$3.34B
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Almirall, S.A.Almirall, S.A.31.81.72%5%2.60.2
$18.01

Current Fair Value

17.4% upside

Undervalued by 17.4% based on the discounted cash flow analysis.

Insider Trades

Loading insider trades…

Congress Trades

Loading congress trades…

Share Statistics

Market cap$3.34 Billion
Enterprise Value$3.23 Billion
Annual dividend$0.22
Dividend yield1.72%
Earnings per Share$0.21
Beta0.18
Outstanding Shares217,742,000

Return

Return on Equity4.72%ROE
Return on Assets3.06%
Return on Invested Capital14.55%

Valuation & Multiples

P/E Ratio31.81P/E Ratio
PEG325.18PEG
Price to Sales2.56Price to Sales
Price to Book Ratio2.19Price to Book Ratio
Enterprise Value to Revenue2.24
Enterprise Value to EBIT10.74
Enterprise Value to Net Income44
Total Debt to Enterprise0.09
Debt to Equity0.18Debt to Equity

Revenue Sources

No data

Last Earnings Call

Report Date
November 9, 2026
EPS Estimate
$0.15
Consensus analyst estimate
Revenue Estimate
$354.30 M
Consensus analyst estimate

Institutional Sentiment (Put/Call)

No data available for the latest quarter.

Institutional Ownership

No data available for the latest quarter.

About Almirall, S.A.

2,097 employees
CEO: Carlos Gallardo Piqué

Almirall, S.A. is a biopharmaceutical firm dedicated to the discovery, development, production, and commercialization of treatments primarily focused on skin health. Operating globally, with a significant presence in Europe and the Unite...

Questions & Answers